Background: This study aimed to identify optimal combinations between feature selection methods and machine-learning classifiers for predicting the metabolic response of individual metastatic breast cancer lesions, based on clinical variables and radiomic features extracted from pretreatment [18F]F-FDG PET/CT images. Methods: A total of 48 patients with confirmed metastatic breast cancer, who received different treatments, were included. All patients had an [18F]F-FDG PET/CT scan before and after the treatment. From 228 metastatic lesions identified, 127 were categorized as responders (complete or partial metabolic response) and 101 as non-responders (stable or progressive metabolic response), by using the percentage changes in SULpeak (pea...
International audienceAs a vital task in cancer therapy, accurately predicting the treatment outcome...
International audienceObjectives: Early prediction of no response to neoadjuvant chemotherapy (NAC) ...
Simple Summary The pathological complete response (pCR) after neoadjuvant chemoradiotherapy (CCRT) i...
Simple Summary Breast cancer is a leading cause of morbidity and mortality worldwide. The metastatic...
Purpose: to investigate the preoperative role of ML-based classification using conventional 18F-FDG ...
Purpose: To assess whether a radiomics and machine learning (ML) model combining quantitative parame...
: In this prospective study, 117 female patients (mean age = 53 years) with 127 histologically prove...
Background: This study aimed to propose a machine learning model to predict the local response of re...
Featured Application Based on results defined in this study, new investigations might propose morpho...
Background: This study investigated the performance of simultaneous 18F-FDG PET/MRI of the breast as...
Purpose: The objective of this study was to evaluate a set of radiomics-based advanced textural feat...
International audienceObjective: The characterization of tumor heterogeneity using radiomic features...
International audiencePurpose: To assess the therapeutic response for metastatic breast cancer with ...
Metastatic breast cancer patients receive lifelong medication and are regularly monitored for diseas...
Funder: Horizon 2020 Framework Programme; doi: http://dx.doi.org/10.13039/100010661Funder: Medical U...
International audienceAs a vital task in cancer therapy, accurately predicting the treatment outcome...
International audienceObjectives: Early prediction of no response to neoadjuvant chemotherapy (NAC) ...
Simple Summary The pathological complete response (pCR) after neoadjuvant chemoradiotherapy (CCRT) i...
Simple Summary Breast cancer is a leading cause of morbidity and mortality worldwide. The metastatic...
Purpose: to investigate the preoperative role of ML-based classification using conventional 18F-FDG ...
Purpose: To assess whether a radiomics and machine learning (ML) model combining quantitative parame...
: In this prospective study, 117 female patients (mean age = 53 years) with 127 histologically prove...
Background: This study aimed to propose a machine learning model to predict the local response of re...
Featured Application Based on results defined in this study, new investigations might propose morpho...
Background: This study investigated the performance of simultaneous 18F-FDG PET/MRI of the breast as...
Purpose: The objective of this study was to evaluate a set of radiomics-based advanced textural feat...
International audienceObjective: The characterization of tumor heterogeneity using radiomic features...
International audiencePurpose: To assess the therapeutic response for metastatic breast cancer with ...
Metastatic breast cancer patients receive lifelong medication and are regularly monitored for diseas...
Funder: Horizon 2020 Framework Programme; doi: http://dx.doi.org/10.13039/100010661Funder: Medical U...
International audienceAs a vital task in cancer therapy, accurately predicting the treatment outcome...
International audienceObjectives: Early prediction of no response to neoadjuvant chemotherapy (NAC) ...
Simple Summary The pathological complete response (pCR) after neoadjuvant chemoradiotherapy (CCRT) i...